(Q35856447)

10 August 2017

1 reference

title

Oligomerisation of angiotensin receptors: novel aspects in disease and drug therapy (English)

1 reference

10 August 2017

author name string

Liza Barki-Harrington

series ordinal

1

1 reference

10 August 2017

publication date

1 June 2004

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

10 August 2017

published in

1 reference

10 August 2017

volume

5

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

49-52

1 reference

Molecular tinkering of G protein-coupled receptors: an evolutionary success

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Roles of G-protein-coupled receptor dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

G-protein-coupled receptor oligomerization and its potential for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Heterodimerization is required for the formation of a functional GABA(B) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

G-protein-coupled receptor heterodimerization modulates receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Anti-adrenergic effects of angiotensin converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

The angiotensin II AT2 receptor is an AT1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Mechanism of action of beta-blocking agents in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Seven-transmembrane-spanning receptors and heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

How activated receptors couple to G proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.009

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2004.009

1 reference

10 August 2017

1 reference